NCT00511459 2015-10-29Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer PatientsAmgenPhase 2 Completed228 enrolled
NCT00752570 2015-09-02A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal CarcinomaAmgenPhase 2 Completed144 enrolled